BETHLEHEM, Pa., July 24,
2024 /PRNewswire/ -- B. Braun Medical Inc. (B.
Braun), the U.S. market leader in regional anesthesia, announced
today that a Midwest children's hospital is the first hospital in
the U.S. to convert to NRFit® Connectors. This milestone
event promotes patient safety by preventing devices meant for
neuraxial administration from connecting to devices used in other
applications. While this is the first NRFit Connector conversion in
the U.S., B. Braun has supported more than 3,000 conversions
worldwide.
NRFit Connectors are the new ISO Standard for neuraxial and
regional anesthesia devices. Currently, the Luer connector is the
most broadly used medical device tubing connector. The universal
design of Luer connectors poses the risk of misconnections which
may result in delivering unintended fluids or gases to patients.
NRFit Connectors are 20% smaller in diameter than Luer connectors,
preventing medical devices meant for neuraxial administration from
connecting to devices used for IV, enteral and other applications,
thus enhancing patient safety.
"B. Braun is pleased to collaborate with this Midwest children's
hospital and GEDSA to initiate the first NRFit Connector conversion
in the U.S. This advancement in patient care is an important step
forward in solving a safety concern in regional anesthesia
procedures," said Jamie Demsey, Sr.
Product Manager of Neuraxial Products and GEDSA board member.
The Global Engineered Device Supplier Association (GEDSA) is a
non-profit trade association formed to help introduce international
standards for healthcare tubing connectors, such as NRFit
Connectors.
While NRFit Connectors are not exclusive to B. Braun products,
the company is uniquely positioned to help U.S. hospitals implement
the connectors which have been widely adopted in other
countries.
To learn more about NRFit Connectors visit
https://www.bbraunusa.com/en/products-and-partnerships/surgical-procedures/regional-anesthesia-and-acute-pain-management/nrfit-connectors.html
About B. Braun
B. Braun Medical Inc. (B. Braun) is a leader in smart infusion
therapy and safe and effective pharmacy products, patient and
provider safety, and sustainable health solutions. Our purpose is
to help providers constantly improve patient satisfaction and
outcomes. With products and services created to help healthcare
professionals focus on what matters most—their patients—we're
uniquely positioned to help health systems succeed now and in the
future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B.
Braun Group of Companies in the U.S., which includes B. Braun
Interventional Systems, Aesculap® and CAPS®.
The company employs 8,500 people at over 30 locations across
North America.
Globally, the B. Braun Group of Companies employs more than
64,000 employees in 64 countries. Guided by its Sharing
Expertise® philosophy, B. Braun continuously exchanges
knowledge with customers, partners and clinicians to address the
critical issues of improving care and lowering costs. To learn more
about B. Braun Medical, explore our website.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/b-braun-medical-announces-first-us-conversion-to-nrfit-connectors-302205448.html
SOURCE B. Braun Medical Inc.